Current prediction tools for colon cancer primarily rely on clinical and pathologic characteristics, such as sex, age, carcinoembryonic antigen (CEA), T stage, and positive lymph nodes, to predict survival outcomes6, 7, 8. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.